Xtandi 40 mg/1 (Enzalutamide CAPSULE) 40 mg/1

Xtandi 40 mg capsules are a prescription medication used in the management of certain prostate conditions. This oral treatment is designed to help control symptoms and may be prescribed as part of a broader therapy plan.

Strength

40 mg/1

Pack Size

56 CAPSULE in 1 BLISTER PACK (0469-1125-56)

Manufacturer / TM Owner

Astellas Pharma US, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Xtandi 40 mg capsules are primarily used in the treatment of advanced prostate cancer. This medication works by targeting specific hormonal pathways to help manage the progression of the disease. Patients often wonder, 'What is Xtandi used for?' and it is typically prescribed for conditions where hormonal therapy is indicated.

Side Effects

Common effects of Xtandi 40 mg capsules may include fatigue, hot flashes, and potential changes in blood pressure. Some users may also experience dizziness or nausea. It is important to discuss any persistent or severe effects with a healthcare provider.

Precautions & Warnings

Xtandi 40 mg capsules should be handled with care and stored as directed. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should avoid activities that require alertness if they experience dizziness.

Avoid Interactions

Xtandi 40 mg capsules may interact with certain medications, including those metabolized by the liver's CYP3A4 enzyme. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.

Frequently Asked Questions

Xtandi 40 mg capsules are used in the treatment of advanced prostate cancer, targeting specific hormonal pathways to manage disease progression.

Xtandi 40 mg capsules are taken orally, typically once daily. Follow the specific instructions provided by your healthcare provider.

Common side effects may include fatigue, hot flashes, dizziness, and nausea. Always consult a healthcare provider for personalized advice.

It is important to discuss alcohol consumption with your healthcare provider, as it may interact with Xtandi 40 mg capsules.

Store Xtandi 40 mg capsules at room temperature, away from moisture and heat. Keep them out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.